Home › NCT06976736

A Long Term Follow-up Study of TScan TCR-T Products

A Long-term Follow-up Study to Assess Safety in Participants Who Received an Investigational T-Cell Receptor Engineered T-Cell (TCR-T) Product

Who can join

Ages 18 to 110 · All sexes

Inclusion Criteria:

* Participants who received a TCR-T cellular therapy in a clinical study sponsored by TScan Therapeutics.
* Signed informed consent.

Exclusion Criteria:

* None

About the study

The purpose of this Long-Term Follow-Up (LTFU) study is to monitor participants who have previously received TSC-100 or TSC-101 TCR-T therapies in the TSCAN-001 study. Participants will be monitored for 15 years from the date of TCR-T cell therapy administration to assess long-term safety and efficacy.

What is being tested

• Observational (other)

Sponsor: TScan Therapeutics, Inc. · Participants: 1,000 · Started: Sep 9, 2025

Contact the study team

• Madhavi Desai · Phone: (857) 399-9832

Official record on ClinicalTrials.gov — NCT06976736

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.